Jones anchored her discussion in a core philosophy for veterinary oncology: "one size does not fit all.” According to Jones, ...

The report charts major advances in precision oncology and immunotherapy but also reveals stagnant survival for several ...

Over the past century, most cancer research has focused on the tumor itself. Rakesh Jain focused on the tumor's environment ...

HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Dec. 08, 2025 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:​HCM; ...

Allied Market Research published a report, titled, "Intracardiac Echocardiography Devices Market by Product (Ultrasound System, Catheter, and Others), Application (Electrophysiology, Left Atrial ...

Four clinical trials to be presented at the 67th American Society of Hematology (ASH) Annual Meeting and Exposition illustrate how advancements in technology are contributing to an improved outlook ...

ChristianaCare’s Helen F. Graham Cancer Center & Research Institute plans to expand its services into Middletown, bringing a ...

When you look at the big players in medical tech, Siemens Healthineers definitely stands out as a major competitor to GE ...

GE HealthCare (Nasdaq: GEHC) announced today that it entered into a new collaboration with Mayo Clinic centered around cancer ...

Focused on radiation therapy, their GEMINI-RT collaboration will prioritize personalized treatments, AI-enabled process automation and multi-modal approaches to connected care.

Perioperative chemotherapy is recommended for patients with cT2-4 and/or N+ resectable gastric cancer, preferably 5-fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT).

GE HealthCare and the Mayo Clinic are expanding their long-running collaborative work to now include the development of new personalized radiation therapy approaches for cancer, with a pl | The ...